Skip to content

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)

Epidemiological Study to Assess the Symptom Patterns and Management Strategies in Patients Consulting With Persistent GERD Symptoms in Primary Care

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00768443
Acronym
PHENIX
Enrollment
2674
Registered
2008-10-08
Start date
2008-09-30
Completion date
2009-02-28
Last updated
2010-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Keywords

GERD, PPI

Brief summary

This a non-interventional multi-centre study to evaluate the symptom load and management strategies in PPI-treated GERD patients with persistent GERD symptoms..

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of informed consent * Subjects with a diagnosis of GERD and with predominant typical GERD symptoms: heartburn/regurgitation * Subjects who fail to obtain satisfactory symptomatic response after their first full course (4-8 weeks) of standard dose PPI (once a day)

Exclusion criteria

* Inability to read and/or understand Patient Reported Outcomes questionnaires * Subjects where the only reason for the visit is renewing the prescription * A history of an incomplete response to PPI treatment prior to current course of treatment

Design outcomes

Primary

MeasureTime frame
To assess the symptom load and impact on daily life in PPI-treated GERD patients with persistent GERD symptomsOnce, at first visit

Secondary

MeasureTime frame
To describe the frequency and severity of extra-oesophageal and/or atypical GERD symptoms and to assess the concordance between patient-reported and physician-reported symptom loadOnce, at first visit
To describe current and previous treatment strategies and to describe the diagnostic and therapeutic approaches during the study visitOnce, at first visit
To describe the impact of persistent GERD symptoms on work productivityOnce, at first visit

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026